Abstract

A novel strategy is presented for reliable diagnosis and progression prediction of diseases with special attention to COVID-19 pandemic. A plan is presented for how the model can be implemented worldwide in healthcare and how novel treatments and targets can be detected. The idea is based on poikilosis, pervasive heterogeneity, and variation at all levels, systems, and mechanisms. Poikilosis in diseases can be taken into account in pathogenicity model, which is based on distribution of three independent condition measures—extent, modulation, and severity. Pathogenicity model is a population or cohort-based description of disease components. Evidence-based thresholds can be applied to the pathogenicity model and used for diagnosis as well as for early detection of patients in risk of developing the most severe forms of the disease. Analysis of patients with differential course of disease can help in detecting biomarkers of diagnostic and prognostic significance. A practical and feasible plan is presented how the concepts can be implemented in practice. Collaboration of many actors, including the World Health Organization and national health authorities, will be essential for success.

Highlights

  • All biological systems are dynamic and show ubiquitous heterogeneity

  • An approach and strategy are presented for how reliable diagnosis, prognosis, and stratification of patients can be achieved

  • A systems biological scheme was presented for identifying processes and levels which can be treated with already available regimes, as well as a path to identify TARAR mechanisms, which can be activated, reinforced, or induced to reduce the effects and consequences of the disease

Read more

Summary

Mauno Vihinen*

A novel strategy is presented for reliable diagnosis and progression prediction of diseases with special attention to COVID-19 pandemic. A plan is presented for how the model can be implemented worldwide in healthcare and how novel treatments and targets can be detected. Poikilosis in diseases can be taken into account in pathogenicity model, which is based on distribution of three independent condition measures—extent, modulation, and severity. Pathogenicity model is a population or cohort-based description of disease components. Evidence-based thresholds can be applied to the pathogenicity model and used for diagnosis as well as for early detection of patients in risk of developing the most severe forms of the disease. A practical and feasible plan is presented how the concepts can be implemented in practice.

INTRODUCTION
CONCEPT OF PATHOGENICITY MODEL
PREDICTION OF DISEASE PROGRESSION
STRATEGY FOR DEVELOPING TREATMENTS
IMPLEMENTATION OF THE NOVEL STRATEGY
SUMMARY
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call